ADVANCES IN ALZHEIMER'S AND PARKINSON'S THERAPIES
AN AAT-AD/PD FOCUS MEETING
15-18 March 2018 | Torino, Italy
The Conference was a huge success, hosting over 1300 participants.
AAT-AD/PDTM 2018 presented all the latest breakthroughs in treatment, translational R&D, early diagnosis, drug development and clinical trials in Alzheimer's, Parkinson's and other related neurological disorders.
A central theme was to further advance innovative strategies in therapy and prevention, clinical trials and diagnostic markers discussed in the sessions and corridors at AD/PDTM 2017, in order to focus on driving successful collaborations among academia and industry, leading to the development of innovative drugs and ultimately providing for a better future for patients and families affected by neurodegenerative diseases.
Conference Website: https://aat-adpd.kenes.com/2018
|Ezio Giacobini, Switzerland,|
|Abraham Fisher, Israel,|
|Gabriel Gold, Switzerland,|
|Roger M. Nitsch, Switzerland,|
|||Manfred Windisch, Austria,|